Avastin Rejected Due To “Lack Of Benefits, Cost”, Officials Explain
Some health officials believe the drug may be beneficial, but it lacked too much to be considered a cost-effective solution for many patients.
Some health officials believe the drug may be beneficial, but it lacked too much to be considered a cost-effective solution for many patients.
New research may benefit infants who are born pre-term and may eventually become blind due to the early birth.
The cancer drug Bevacizumab, also known as Avastin, was found to be dangerous for individuals who are taking the drug and undergoing chemotherapy.